These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 10766357)
1. B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity. Selmayr M; Menzel H; Kremer JP; Thierfelder S; Mocikat R Cancer Gene Ther; 2000 Mar; 7(3):501-6. PubMed ID: 10766357 [TBL] [Abstract][Full Text] [Related]
2. Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype. Selmayr M; Strehl J; Kremer JP; Kremmer E; Doenecke A; Hallek M; Menzel H; Thielemans K; Thierfelder S; Mocikat R Gene Ther; 1999 May; 6(5):778-84. PubMed ID: 10505101 [TBL] [Abstract][Full Text] [Related]
3. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. Syrengelas AD; Levy R J Immunol; 1999 Apr; 162(8):4790-5. PubMed ID: 10202021 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547 [TBL] [Abstract][Full Text] [Related]
5. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Ruffini PA; Neelapu SS; Kwak LW; Biragyn A Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812 [TBL] [Abstract][Full Text] [Related]
6. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants. Benvenuti F; Burrone OR Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816 [TBL] [Abstract][Full Text] [Related]
8. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model. Kwak LW; Campbell M; Levy R Cancer Detect Prev; 1991; 15(4):323-5. PubMed ID: 1794139 [TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection. Benvenuti F; Burrone OR; Efremov DG Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells. Fredriksen AB; Sandlie I; Bogen B Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309 [TBL] [Abstract][Full Text] [Related]
11. Boosting anti-idiotype immune response with recombinant AAV enhances tumour protection induced by gene gun vaccination. Cesco-Gaspere M; Zentilin L; Giacca M; Burrone OR Scand J Immunol; 2008 Jul; 68(1):58-66. PubMed ID: 18482206 [TBL] [Abstract][Full Text] [Related]
12. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. Campbell MJ; Esserman L; Byars NE; Allison AC; Levy R J Immunol; 1990 Aug; 145(3):1029-36. PubMed ID: 2373859 [TBL] [Abstract][Full Text] [Related]
13. Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine. Lim SY; Laxmanan S; Stuart G; Ghosh SK Cancer Detect Prev; 2001; 25(5):470-8. PubMed ID: 11718453 [TBL] [Abstract][Full Text] [Related]
14. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity. Mocikat R; Selmayr M; Thierfelder S; Lindhofer H Cancer Res; 1997 Jun; 57(12):2346-9. PubMed ID: 9192805 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model. Rinaldi M; Fioretti D; Iurescia S; Signori E; Pierimarchi P; Seripa D; Tonon G; Fazio VM Biochem Biophys Res Commun; 2008 May; 370(2):279-84. PubMed ID: 18364239 [TBL] [Abstract][Full Text] [Related]
16. Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein. Kaminski MS; Kitamura K; Maloney DG; Levy R J Immunol; 1987 Feb; 138(4):1289-96. PubMed ID: 3492546 [TBL] [Abstract][Full Text] [Related]
17. A nine-amino acid peptide from IL-1beta augments antitumor immune responses induced by protein and DNA vaccines. Hakim I; Levy S; Levy R J Immunol; 1996 Dec; 157(12):5503-11. PubMed ID: 8955200 [TBL] [Abstract][Full Text] [Related]
18. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope. Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555 [TBL] [Abstract][Full Text] [Related]
19. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853 [TBL] [Abstract][Full Text] [Related]
20. Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma. Tao MH; Levy R Nature; 1993 Apr; 362(6422):755-8. PubMed ID: 8469286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]